Sequoia-backed MedGenome raises $55 Mn led by Novo Holdings


Content Team
Image Credit: entracker

MedGenome, a genetic diagnostics, research, and data company, has secured $50 million led by Novo Holdings, a Denmark-based life science venture capital investor. The Bengaluru and Delaware-headquartered company also roped in existing backers LeapFrog Investments and Sofina in the new round. LeapFrog led a $55 million round in MedGenome in April 2020.